Megan Johnson has resigned from the BFS IOA Board as she has left Nephron Pharmaceuticals Corporation and no longer work with BFS technology. Her position as Board member is therefore on vote at the upcoming Annual General meeting in Liverpool on July 1st, 2015. 

The Board would like to thank Megan Johnson for her excellent work and her support of BFS IOA.